{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:03:26Z","timestamp":1759334606768,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.arcmed.2010.10.012","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T04:11:54Z","timestamp":1294114314000},"page":"651-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Methionine Sulfoximine May Improve Inflammation in Autism, A Novel Hypothesized Treatment for Autism"],"prefix":"10.1016","volume":"41","author":[{"given":"Ahmad","family":"Ghanizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"176","key":"10.1016\/j.arcmed.2010.10.012_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2006.07.025","article-title":"Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders","volume":"10","author":"MacFabe","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.arcmed.2010.10.012_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-3223(93)90017-8","article-title":"A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes","volume":"33","author":"Minshew","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.arcmed.2010.10.012_bib3","series-title":"Phospholipid Spectrum Disorder in Psychiatry","article-title":"A possible role for phospholipases in autism and Asperger\u2019s syndrome","author":"Horrobin","year":"1999"},{"key":"10.1016\/j.arcmed.2010.10.012_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2009.06.003","article-title":"Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism","volume":"81","author":"Pastural","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.arcmed.2010.10.012_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/appi.ajp.161.4.662","article-title":"Linkage and association of the mitochondrial aspartate\/glutamate carrier SLC25A12 gene with autism","volume":"161","author":"Ramoz","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.arcmed.2010.10.012_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/092986709787002745","article-title":"Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders","volume":"16","author":"Blaylock","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.arcmed.2010.10.012_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","article-title":"Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism","volume":"27","author":"Niederhofer","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.arcmed.2010.10.012_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcmed.2010.10.012_bib9","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1176\/appi.ajp.162.11.2182","article-title":"Confirmation of association between autism and the mitochondrial aspartate\/glutamate carrier SLC25A12 gene on chromosome 2q31","volume":"162","author":"Segurado","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.arcmed.2010.10.012_bib10","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2010.10.012_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2010.10.012_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1073\/pnas.84.3.881","article-title":"Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A","volume":"84","author":"Krause","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2010.10.012_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-2236(99)01533-7","article-title":"A new concept in neurodegeneration: TNFalpha is a silencer of survival signals","volume":"23","author":"Venters","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.arcmed.2010.10.012_bib14","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"15","author":"Tikka","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2010.10.012_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2005.04.025","article-title":"Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats","volume":"165","author":"Chaparro-Huerta","year":"2005","journal-title":"J Neuroimmunology"},{"key":"10.1016\/j.arcmed.2010.10.012_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2010.10.012_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2009.11.013","article-title":"Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS","volume":"290","author":"Ghoddoussi","year":"2010","journal-title":"J Neurol Sci"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440910003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440910003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:38:51Z","timestamp":1759261131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440910003073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0188440910003073"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2010.10.012","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methionine Sulfoximine May Improve Inflammation in Autism, A Novel Hypothesized Treatment for Autism","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2010.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}